Health

SoftBank invested $125m through a $160m private placement as portfolio company and cancer drug developer Exscientia went public in an offering sized at nearly $305m.

The Fosun-backed ophthalmology equipment provider raised cash that will go to research, recruitment and commercialisation activities.

Boehringer Ingelheim Venture Fund and Pierre Fabre have made capital commitments to Advent France Biotechnology’s second fund.

The Sony-backed surgical robotics developer has raised $87m in total having received series B funding from investors including Nvidia.

The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.

Online reselling platform developer Meesho attracted corporate investors Facebook, SoftBank and Prosus Ventures for a multimillion-dollar round, valuing it at $4.9bn.

Corporate-backed asset management software developer Zero Hash raised $35m in series C funding while warehouse robotics provider VisionNav closed its own series C round.

Tencent, Nikon, Amgen and Illumina all scored exits as the DNA sequencing provider's shares popped in the wake of its flotation.

The AL amyloidosis treatment developer is being taken over AstraZeneca, the parent company of existing investor Alexion.

Altria-backed Micreos is working on a clinical platform that will facilitate the targeted killing of unwanted bacteria, and has just secured $37.5m.